Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex
Single-nucleus analysis reveals dysregulated oxidative phosphorylation in Down syndrome basal forebrain at birth
Timeline to symptomatic Alzheimer’s disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study
The effects of mosaicism on biological and clinical markers of Alzheimer’s disease in adults with Down syndrome
The complexity of opportunities to respond used by mothers and fathers of children with Down syndrome: A preliminary investigation